Docefrez

E902897

Docefrez is a branded formulation of the chemotherapy drug docetaxel used to treat various cancers, including breast, lung, and prostate cancer.

All labels observed (1)

Label Occurrences
Docefrez canonical 1

How this entity was disambiguated

Statements (39)

Predicate Object
instanceOf chemotherapy drug
pharmaceutical brand
administeredBy healthcare professional
affects microtubule depolymerization
belongsToClass taxane chemotherapy
causes apoptosis in cancer cells
commonAdverseEffect alopecia
anemia
fatigue
nausea
neutropenia
peripheral neuropathy
contains docetaxel anhydrous
contraindicatedIn severe hepatic impairment
drugClass antineoplastic agent
formulationType injectable concentrate
hasActiveIngredient docetaxel NERFINISHED
indicatedFor hormone-refractory metastatic prostate cancer
locally advanced breast cancer
metastatic breast cancer
metastatic non-small cell lung cancer
induces cell cycle arrest at G2/M phase
mayCause hypersensitivity reactions
mechanismOfAction microtubule stabilizer
mitotic inhibitor
oftenGivenWith corticosteroid premedication
originatesFrom semi-synthetic derivative of paclitaxel-related compounds
pregnancyCategory teratogenic risk
regulatoryStatus prescription-only medicine
requires dilution before infusion
prescription
requiresMonitoring blood cell counts
routeOfAdministration intravenous infusion
storageCondition controlled room temperature
targets rapidly dividing cells
usedFor breast cancer
cancer treatment
non-small cell lung cancer
prostate cancer

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

docetaxel tradeName Docefrez
subject surface form: Docetaxel